Detalhe da pesquisa
1.
Is the price right? Paying for value today to get more value tomorrow.
BMC Med
; 22(1): 45, 2024 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287326
2.
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework.
Value Health
; 27(4): 433-440, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191022
3.
Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015-2019.
Value Health
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38663800
4.
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations.
Future Oncol
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258557
5.
A review of economic issues for gene-targeted therapies: Value, affordability, and access.
Am J Med Genet C Semin Med Genet
; 193(1): 64-76, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854952
6.
Value-Based Pricing for Patent-Protected Medicines Over the Product Life Cycle: Pricing Anomalies in the "Age of Cures" and Their Implications for Dynamic Efficiency.
Value Health
; 26(3): 336-343, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336584
7.
Is the world ready for gene therapy?
Haemophilia
; 28 Suppl 2: 5-8, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318781
8.
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer.
J Natl Compr Canc Netw
; 20(10): 1107-1115.e12, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240855
9.
The History and Future of the "ISPOR Value Flower": Addressing Limitations of Conventional Cost-Effectiveness Analysis.
Value Health
; 25(4): 558-565, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279370
10.
A Pragmatic Guide to Assessing Real Option Value for Medical Technologies.
Value Health
; 2022 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752536
11.
Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysis.
Qual Life Res
; 31(1): 185-191, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34219192
12.
Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of "Failed" R&D Efforts.
Int J Technol Assess Health Care
; 38(1): e31, 2022 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297363
13.
Modeling the Ex Post Real Option Value in Metastatic Melanoma Using Real-World Data.
Value Health
; 24(12): 1746-1753, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838272
14.
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations.
Value Health
; 24(11): 1628-1633, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711363
15.
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?
Value Health
; 24(12): 1828-1834, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838281
16.
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?
Cost Eff Resour Alloc
; 19(1): 13, 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33648523
17.
Toward a broader concept of societal value: family spillovers in Alzheimer's disease.
Int J Technol Assess Health Care
; 38(1): e7, 2021 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317687
18.
Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next?
Value Health
; 27(1): 3-6, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37918665
19.
How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic Melanoma.
Value Health
; 22(7): 777-784, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31277824
20.
Defining and Managing High-Priced Cures: Healthcare Payers' Opinions.
Value Health
; 22(6): 648-655, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31198181